Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Creative Testing Solutions
The InnoLIA HTLV I/II Score study consists of three sub-studies. The first sub-study will determine the sensitivity, specificity and accuracy of HTLV type assignment using well-characterized samples from the NIH-funded HTLV Outcomes Study (HOST). The second sub-study will compare automated reading and interpretation of test results with manual reading and interpretation using a sub-set of samples tested in the initial study. The third sub-study allows for use of the InnoLIA HTLV I/II Score as a supplemental test for whole blood and HCT/P donors testing repeatedly reactive with an FDA-approved donor screening test for anti-HTLV-I/II.
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subjects completing a health history evaluation for routine donor screening
Subjects willing and able to provide informed consent
Subjects testing repeat reactive on a licensed screening test for HTLV antibodies
You may not be if
Subjects not meeting health history criteria for routine donor screening
Subjects unwilling and unable to provide informed consent
Subjects testing negative on a licensed screening test for HTLV antibodies
Clareo Health | Evaluation of InnoLIA HTLV I/II Score
